Thyroid dysfunction in a UK hepatitis C population treated with interferon‐α and ribavirin combination therapy

Abstract

Although TD was common in this cohort, just 2.3% developed TD that required ongoing therapy. Pre-IFN/RBV serum TSH and TPO antibody titre were found to predict progression to TD in this group of patients.